PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
BIRMINGHAM, Mich.--(BUSINESS WIRE)--UBS Wealth Management USA today announced that Denise Meulebrouck has joined the firm as a Financial Advisor based in Birmingham, Michigan. She brings more than 27
Banks regarded as too big to fail are sufficiently capitalized, UBS Chairman Colm Kelleher said on Thursday, as his bank seeks to avoid regulations currently taking shape in Switzerland that could hur
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chie
CUPERTINO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies
BEIJING , Oct. 31, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that Mr. Steven Sim,
Brenda O'Connor Juanas expects solid earnings in the tech space, adding that the macro environment remains supportive for equities, and financials and utilities look attractive from a valuation standp
Apple Inc (NASDAQ:AAPL, ETR:APC)'s flagship artificial intelligence (AI) launch has underwhelmed, leaving the technology giant in need of a “killer” use case to drive iPhone demand, UBS analysts s
UBS' third-quarter 2024 results reflect strong growth in the Global Wealth Management, Asset Management and Investment Bank divisions.
UBS Group AG (NYSE:UBS ) Q3 2024 Earnings Conference Call October 30, 2024 4:00 AM ET Company Participants Sarah Mackey – Head, IR Sergio Ermotti - Group CEO Todd Tuckner - Group CFO Conference Call

UBS (UBS) Tops Q3 Earnings and Revenue Estimates

08:05am, Wednesday, 30'th Oct 2024
UBS (UBS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to loss of $0.24 per share a year ago.
MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
UBS remains in "technical discussions" with the Swiss government about its plans for the bank to hold more capital but is yet to receive feedback, CEO Sergio Ermotti said on Wednesday.
Stocks are now expected to weaken versus bonds, argue UBS strategists.
"We do expect, no matter who wins and the outcome, we do expect some market movements. And it remains to be seen how investors will react," Ermotti added.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE